LENZ Therapeutics (LENZ) Insider Trading & Ownership $25.64 -0.89 (-3.35%) Closing price 04:00 PM EasternExtended Trading$25.66 +0.02 (+0.10%) As of 04:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock LENZ Therapeutics (NASDAQ:LENZ) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage38.40%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$500,998.68Number OfInsiders Selling(Last 12 Months)0 Get LENZ Insider Trade Alerts Want to know when executives and insiders are buying or selling LENZ Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address LENZ Insider Buying and Selling by Quarter Remove Ads LENZ Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/13/2024James W MccollumDirectorBuy31,332$15.99$500,998.68 (Data available from 1/1/2013 forward) LENZ Insider Trading Activity - Frequently Asked Questions Who is on LENZ Therapeutics's Insider Roster? The list of insiders at LENZ Therapeutics includes James W Mccollum, and Ra Capital Management, L.P.. Learn more on insiders at LENZ. What percentage of LENZ Therapeutics stock is owned by insiders? 38.40% of LENZ Therapeutics stock is owned by insiders. Learn more on LENZ's insider holdings. Which LENZ Therapeutics insiders have been buying company stock? The following insiders have purchased LENZ shares in the last 24 months: James W Mccollum ($500,998.68), and Ra Capital Management, L.P. ($15,000,075.27). How much insider buying is happening at LENZ Therapeutics? Insiders have purchased a total of 1,029,341 LENZ shares in the last 24 months for a total of $15,501,073.95 bought. LENZ Therapeutics Key ExecutivesMr. Evert B. Schimmelpennink (Age 52)President, CEO, Secretary & Director Compensation: $886.54kMr. Shawn Olsson (Age 41)Chief Commercial Officer Compensation: $532.13kMr. Marc G. Odrich M.D. (Age 65)Chief Medical Officer Compensation: $576.95kMr. James W. McCollum (Age 69)Co-Founder & Director Mr. Gerald HornSenior Scientific Advisor & FounderMr. Daniel R. Chevallard CPA (Age 44)Chief Financial Officer Mr. Domenick PorfidiaVice President of SalesMr. David MurphySenior Director of Marketing & Alliance DevelopmentMr. Marvin J. Garrett (Age 73)Senior Vice President of Regulatory & Quality More Insider Trading Tools from MarketBeat Related Companies NAMS Insider Trading TWST Insider Trading EWTX Insider Trading IBRX Insider Trading MLTX Insider Trading BEAM Insider Trading VCEL Insider Trading CNTA Insider Trading DNLI Insider Trading KYMR Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles NVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish 3 Companies Buying Back Stock—Why It Matters This page (NASDAQ:LENZ) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredTrump’s Treasure Map [Pic inside]We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men...Paradigm Press | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredAI Boom Takes a Shocking Turn…A potentially historic moment for retirement Let's make the most of this market together. Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LENZ Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LENZ Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LENZ Stock Free LENZ Stock Alerts